ADHD-Flagged Cardiovascular Risk Score for Primary Care
A tool for doctors to identify heart health risks in adults with ADHD.
An EHR module that treats an ADHD diagnosis as a risk-enhancing input in standard 10-year cardiovascular risk calculators, prompting earlier blood-pressure and lipid screening for adults with ADHD — because the risk comes from the disorder itself, not the medication.
Concept
An add-on for primary-care EHRs and population-health platforms that adds one new input to the cardiovascular risk calculators clinicians already run: an ADHD diagnosis code on the problem list. When present, the module (1) flags ADHD as a risk enhancer, analogous to family history or chronic inflammatory disease; (2) recommends blood-pressure and lipid screening earlier than age-based thresholds would trigger (relevant because the underlying risk is elevated even in younger adults); and (3) displays a one-line evidence note for the clinician: the excess cardiovascular risk travels with the diagnosis, not with stimulant treatment, so it persists whether or not the patient is medicated. The wedge is deliberately narrow — one field added to existing risk scoring, no new clinic workflow and no ADHD-specialty involvement required.
Why now
Paper [0] (5,389,519 Swedish adults, mean 11.8 years follow-up) establishes ADHD as an independent cardiovascular risk factor: 38.05% of adults with ADHD versus 23.57% without had at least one cardiovascular diagnosis; HR 2.05 adjusted for sex and birth year, still 1.84 after adjusting for education, type 2 diabetes, obesity, dyslipidemia, sleep problems and heavy smoking, and 1.65 after psychiatric comorbidities. The strongest signals were cardiac arrest (HR 2.28), hemorrhagic stroke (2.16) and peripheral vascular disease (2.05), with stronger associations in males and younger adults — exactly the group that falls below usual screening ages. Paper [2] (meta-analysis of 19 studies, 3,931,532 participants) shows ADHD medications carry no statistically significant cardiovascular risk in any age group (children RR 1.18; young/middle-aged adults 1.04; older adults 1.59; stimulants 1.24 vs nonstimulants 1.22), meaning medication-focused monitoring alone misses most of the excess risk — the diagnosis itself is the actionable flag. Older corpus paper [6] first raised the long-term medication question, which [2] shows remains open (median follow-up only 1.5 years), reinforcing that the diagnosis, not the prescription, is what primary care should act on today.
Written by GLM · 12 Oct 2026
AI assessment
A highly focused, evidence-backed EHR integration that converts a diagnosis code into a clinical risk-enhancer to trigger earlier cardiovascular screening in a high-risk, under-screened population.
- Evidence strength 5/5
- The idea is strongly supported by a massive cohort study (5.3M people) showing ADHD as an independent risk factor and a meta-analysis confirming that the risk is not primarily driven by medication.
- Market pull 4/5
- Population health managers (Kaiser, CDC) have high incentives to reduce cardiovascular events in younger adults, though adoption depends on EHR integration hurdles.
- Novelty & moat 4/5
- Unlike previous catalog ideas that focus on medication monitoring or general checklists, this specifically targets the diagnosis as a risk-enhancer within standard CVD calculators.
- Feasibility 5/5
- The technical implementation is trivial: it is a logic-based trigger based on an existing ICD code within an EHR.
- Wedge clarity 5/5
- The wedge is exceptionally sharp: adding a single input field to an existing calculator to trigger a specific screening action.
- Simplicity / focus 5/5
- It avoids 'platform' creep by focusing on one specific clinical trigger and one specific outcome (earlier screening).
Scored by Gemma 4 · 12 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.
Persona discussion
AI personas trained on real people's expertise debate this idea as it evolves.
View the discussion →Act on this idea
Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.
Who benefits
- Kaiser Permanenteorganization
As an integrated delivery system with registry-based care and its own risk-prediction infrastructure, it could implement ADHD-flagged cardiovascular prevention across its adult membership and measure downstream event reduction.
- Epic Systemscompany
Its EHR embeds clinical decision support and risk calculators; adding ADHD as a risk-enhancing variable is a small, high-leverage feature for its primary-care customer base.
Its national prevention campaigns target under-recognized risk groups; adults with ADHD are a newly quantified, medication-independent high-risk population it could reach through existing channels.
- American Heart Associationorganization
It maintains cardiovascular risk-factor guidance and prevention campaigns; the new independent evidence base gives it grounds to recognize ADHD as a risk-enhancing factor in adult prevention.
Research it builds on
- Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular DiseasesLe Zhang, Lin Li, Pontus Andell et al. · 2023 · 148 citationsAll ideas from this paper →
- Attention‐deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population‐based cohort studyLin Li, Zheng Chang, Jiangwei Sun et al. · 2022 · 107 citationsAll ideas from this paper →
- Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity DisorderLe Zhang, Honghui Yao, Lin Li et al. · 2022 · 99 citationsAll ideas from this paper →